Increasing attention is now being paid to differences in cell death under various pathological and physiological conditions. The article on nomenclature in the present issue (2) is particularly important for dispelling the confusion that has arisen in this area.
Pathologists have long been aware that various toxic stimuli-aggressive or passive, exogenous or endogenous, including ischemia-induce death at the level of individual cells or groups of cells. This phenomenon is termed &dquo;necrosis,&dquo; from the Greek word for death. The ad hoc committee responsible for the report argues that all types of cell death must be included, by definition, in &dquo;necrosis,&dquo; and that action against the prevailing misconception of a dichotomy between apoptosis and necrosis requires all our efforts.
Majno and Joris' (3) recommendation to apply the term &dquo;oncosis,&dquo; originally coined by von Recklinghausen (4) from the Greek onco, or swelling, to describe the process of cell death associated with cloudy swelling has merit, although, as is stressed by the committee, this term must be strictly differentiated from &dquo;oncology.&dquo; The use of morphological features as the basis for distinction of types of cell death is essential. Viewing of tissue sections gives an accurate picture of cell death occurring in a tissue, allowing a clear distinction between oncosis and apoptosis, or cell death associated with shrinkage.
No nomenclature can be complete without taking into account the mechanisms underlying the process to be named. Molecular, biological, and biochemical investigations continue to provide new insights into the complexity of events leading to all death. The essential differences and similarities between apoptosis and oncosis remain to be strictly defined, assuming that this is possible without any tissue or organ specificity. To a large extent, this latter question still has to be clarified, but an appropriate system is needed now, especially by toxicological pathologists and others involved in regulatory procedures.
Histopathologically, various types of necrosis have been distinguished by taking into account features reflecting causation. Death that occurs subsequent to prelethal degeneration is classified in classical pathology text books into two main categories: coagulation necrosis and liquefaction (colliquation) necrosis. Furthermore, caseation (caseous necrosis) and fat necrosis have been dealt with as special types of necrosis. The emphasis in these distinctions was on change at the tissue level. However, since 1972, when Kerr, Wylie, and Currie proposed the term &dquo;apoptosis&dquo; for a type of cell death distinct from that normally understood as necrosis ( 1 ), attention has shifted to the individual cell level. Extensive interest has naturally been generated in the possibility of switching on a pathway leading to &dquo;programmed cell death,&dquo; with obvious implications for cancer therapy, for example. The problem is that in recent years there has been a tendency for scientific researchers to use the term &dquo;apoptosis&dquo; without precise definition. To be comprehensive and to overcome this difficulty, the nomenclature should take into account etiology as well as morphology, at both the cell and tissue levels.
While application of the terms &dquo;spontaneous&dquo; and &dquo;in-duced&dquo; is not without complications, there might be some merit in employing these, or &dquo;endogenous&dquo; and &dquo;exogenous,&dquo; together with &dquo;single,&dquo; &dquo;scattered,&dquo; and &dquo;local-ized&dquo; at the tissue level, as qualifying terms with either oncosis or apoptosis. Although it would introduce further complexity, there may be grounds for additional morphological qualification on the basis of changes, such as fat droplet accumulation, observed in the surrounding cells. &dquo;Apoptotic cell death&dquo; and &dquo;programmed cell death&dquo; are often used interchangeably. Although they may possess common mechanistic processes, it might be advantageous to recognize them as separate entities, because programmed cell death typically occurs in the embryological developmental period. In programmed cell death, specific types of cells are programmed to die by gene activation at specific sites within organs and at specific times in order to accomplish normal body and organ architecture.
The molecular mechanisms responsible for oncosis are not fully understood, and there is an obvious possibility that oncosis and apoptosis may share common molecular pathways at an early stage. Cell death might be initiated by activation of a common trigger, and then, depending on strength or magnitude and on types of cell injury stimuli, cells may exhibit &dquo;necrosis morphology&dquo; or apoptosis.
Clearly, the cell death story has many episodes left to run, but the ad hoc committee of the Society of Toxicologic Pathologists has made a good start with their contribution on nomenclature. At present, we all need to do our best to disseminate the views expressed in the article. The included photographic examples are very helpful in clarifying the characteristics of each category of cell death. The additional explanation of morphological com-plications of cell death and the examples provided are also of great assistance. However, publication of an atlas demonstrating more examples of all types of cell death under different circumstances would greatly facilitate understanding. This is particularly important in developing techniques for qualification. The committee rightly raises objections to the TUNEL method for its nonspecificity, and we must now concentrate on developing new methodologies.
Global discussion of the new proposed classification of cell death in workshops or conferences now needs promotion. In this activity, the International Federation of Societies of Toxicologic Pathologists can play an important role in achieving an international consensus. Exten-sive communication with people of all specialties working in regulatory agencies is of high priority in order to generate acceptance of this proposal.
